Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

completed480%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants

NCT05167565
completed

Screening of Postpartum Depression in Egyptian Women

NCT05997953
completed

Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19

NCT04769700
completed

mHealth for Antenatal Mental Health

NCT02516982
unknownphase_2

Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale

NCT00251342

Clinical Trials (5)

Showing 5 of 5 trials
NCT05167565Not Applicable

Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants

Completed
NCT05997953

Screening of Postpartum Depression in Egyptian Women

Completed
NCT04769700

Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19

Completed
NCT02516982

mHealth for Antenatal Mental Health

Completed
NCT00251342Phase 2

Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale

Unknown

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5